Journal Article
Print(0)
Annals of laboratory medicine
Ann.Lab.Med.
Nov
32
6
426
428
LR: 20150222; JID: 101571172; 0 (Antifungal Agents); 0 (Pyrimidines); 0 (Triazoles); 7XU7A7DROE (Amphotericin B); 8VZV102JFY (Fluconazole); D83282DT06 (Flucytosine); JFU09I87TR (Voriconazole); OID: NLM: PMC3486937; OTO: NOTNLM; 2012/06/07 [received]; 2012
Korea (South)
2234-3814; 2234-3806
PMID: 23130342
eng
Journal Article; Research Support, Non-U.S. Gov't; IM
10.3343/alm.2012.32.6.426 [doi]
Unknown(0)
23130342
The in vitro antifungal susceptibility of 636 Candida bloodstream isolates collected from 15 tertiary hospitals in Korea was determined using the Vitek-2 yeast susceptibility system (bioMerieux, France). Overall susceptibility rates were 98.1%, 95.9%, 99.1%, and 97.3% for amphotericin B, fluconazole, voriconazole, and flucytosine, respectively. The results show that the rates of resistance to 4 antifungal drugs remain low among Candida bloodstream isolates in Korea.
Jung,S.I., Shin,J.H., Choi,H.J., Ju,M.Y., Kim,S.H., Lee,W.G., Park,Y.J., Lee,K., Korean Study Group for Candidemia
Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
20121017
PMC3486937
http://vp9py7xf3h.search.serialssolutions.com/?charset=utf-8&pmid=23130342
2012